Exosomes combined with biomaterials in the treatment of spinal cord injury
Open accessThe DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Abstract
Spinal cord injury (SCI) is a serious and disabling disease with a high mortality rate. It often leads to complete or partial sensory and motor dysfunction and is accompanied by a series of secondary outcomes, such as pressure sores, pulmonary infections, deep vein thrombosis in the lower extremities, urinary tract infections, and autonomic dysfunction. Currently, the main treatments for SCI include surgical decompression, drug therapy, and postoperative rehabilitation. Studies have shown that cell therapy plays a beneficial role in the treatment of SCI. Nonetheless, there is controversy regarding the therapeutic effect of cell transplantation in SCI models. Meanwhile exosomes, as a new therapeutic medium for regenerative medicine, possess the advantages of small size, low immunogenicity, and the ability to cross the blood-spinal cord barrier. Certain studies have shown that stem cell-derived exosomes have anti-inflammatory effects and can play an irreplaceable role in the treatment of SCI. In this case, it is difficult for a single treatment method to play an effective role in the repair of neural tissue after SCI. The combination of biomaterial scaffolds and exosomes can better transfer and fix exosomes to the injury site and improve their survival rate. This paper first reviews the current research status of stem cell-derived exosomes and biomaterial scaffolds in the treatment of SCI respectively, and then describes the application of exosomes combined with biomaterial scaffolds in the treatment of SCI, as well as the challenges and prospects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“EVs have gained significant attention in CNS injuries, specifically traumatic brain injuries (TBI) and spinal cord injuries (SCI), due to their intricate involvement in injury response, repair processes, and their potential applications as therapeutic agents and biomarkers [175–177].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [176]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third dimension bridges the gap between cell culture and live tissue
Pampaloni, F., Reynaud, E. G., & Stelzer, E. H. K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2236 · Cited by 2,817
Designing Cell-Compatible Hydrogels for Biomedical Applications
Seliktar, D. (2012) · Science · doi:10.1126/science.1214804 · Cited by 1,923 · cited 1×
“There are four main properties for biomedical applications: degradability, adhesion, bioactivity, and mechanical properties (Seliktar, 2012).”
BackgroundFunctional delivery of viral miRNAs via exosomes
Pegtel, D. M., Cosmopoulos, K., Thorley-Lawson, D. A., van Eijndhoven, M. A. J., Hopmans, E. S., Lindenberg, J. L., de Gruijl, T. D., Würdinger, T., & Middeldorp, J. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914843107 · Cited by 1,641 · cited 1×
“Exosomes have emerged as a promising vehicle for miRNA delivery to the central nervous system (Pegtel et al., 2010; Sancho-Albero et al., 2019).”
BackgroundBioinks for 3D bioprinting: an overview
Gungor-Ozkerim, P. S., Inci, I., Zhang, Y. S., Khademhosseini, A., & Dokmeci, M. R. (2018) · Biomaterials Science · doi:10.1039/c7bm00765e · Cited by 1,428
Spinal Cord Injury: Pathophysiology, Multimolecular Interactions, and Underlying Recovery Mechanisms
Anjum, A., Yazid, M. D., Fauzi Daud, M., Idris, J., Ng, A. M. H., Selvi Naicker, A., Ismail, O. H. R., Athi Kumar, R. K., & Lokanathan, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207533 · Cited by 1,270 · cited 1×
“Secondary injury is a pathological process caused after the primary injury that includes continuous hemorrhage, neuroinflammation, oxidative stress, and edema leading to massive necrosis, which in turn trigger free radical formation, glutamate-mediated excitotoxicity, and neurotoxicity (Anjum et al., 2020).”
BackgroundExosome Theranostics: Biology and Translational Medicine
He, C., Zheng, S., Luo, Y., & Wang, B. (2018) · Theranostics · doi:10.7150/thno.21945 · Cited by 1,249 · cited 1×
“Exosomes are vesicles that are continuously released by cells to the extracellular environment, with a diameter of about 40–100 nm, and contain a variety of biomolecules such as lipids, proteins and nucleic acids (He et al., 2018).”
BackgroundExtracellular matrix-based materials for regenerative medicine
Hussey, G. S., Dziki, J. L., & Badylak, S. F. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0023-x · Cited by 844 · cited 1×
“The extracellular matrix contains intrinsic biochemical and mechanical signals that play an irreplaceable role in regulating the phenotype and function of cell development, homeostasis, and response to injury (Hussey et al., 2018).”
BackgroundBiomimetic 3D-printed scaffolds for spinal cord injury repair
Koffler, J., Zhu, W., Qu, X., Platoshyn, O., Dulin, J. N., Brock, J., Graham, L., Lu, P., Sakamoto, J., Marsala, M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0296-z · Cited by 708 · cited 1×
“3D bioprinting technology has been applied to a variety of tissues including bone, cartilage, vascular systems, muscle and heart, but there are relatively few studies regarding SCI (Koffler et al., 2019; Sun et al., 2019; Hou et al., 2022).”
BackgroundLiu, W., Rong, Y., Wang, J., Zhou, Z., Ge, X., Ji, C., Jiang, D., Gong, F., Li, L., Chen, J., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1726-7 · Cited by 573 · cited 1×
“Recent studies suggest that the role of MSCs in the treatment of SCI is attributed to their paracrine mechanism and that exosomes may play an important role in this process (Lee et al., 2020; Liu et al., 2020).”
BackgroundSpinal cord repair: advances in biology and technology
Courtine, G., & Sofroniew, M. V. (2019) · Nature Medicine · doi:10.1038/s41591-019-0475-6 · Cited by 508 · cited 1×
“Biomaterials have promising applications in enhancing spinal cord injury repair (Courtine and Sofroniew, 2019).”
BackgroundDifferentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro
Baharvand, H., Hashemi, S. M., Kazemi Ashtiani, S., & Farrokhi, A. (2006) · The International Journal of Developmental Biology · doi:10.1387/ijdb.052072hb · Cited by 429 · cited 1×
“In contrast, the stem cells cultured in the 3D system show a more accurate cell behavior model in terms of cell attachment, viability, self-renewal, migration, and differentiation (Baharvand et al., 2006).”
BackgroundGuo, S., Perets, N., Betzer, O., Ben-Shaul, S., Sheinin, A., Michaelevski, I., Popovtzer, R., Offen, D., & Levenberg, S. (2019) · ACS Nano · doi:10.1021/acsnano.9b01892 · Cited by 424
Li, L., Zhang, Y., Mu, J., Chen, J., Zhang, C., Cao, H., & Gao, J. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c00929 · Cited by 404
Fan, L., Liu, C., Chen, X., Zheng, L., Zou, Y., Wen, H., Guan, P., Lu, F., Luo, Y., Tan, G., et al. (2022) · Advanced Science · doi:10.1002/advs.202105586 · Cited by 401
Brennan, M. Á., Layrolle, P., & Mooney, D. J. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909125 · Cited by 396 · cited 2×
“In the process of SCI repair, cell-derived exosomes are an extremely beneficial factor in the treatment of SCI, whereas, direct injection of cellderived exosomes into the SCI site has some limitations: 1) the most common way to delivery exosomes into the sites of injury is via local injection, nevertheless, thismay le…”
BackgroundReducing Pericyte-Derived Scarring Promotes Recovery after Spinal Cord Injury
Dias, D. O., Kim, H., Holl, D., Werne Solnestam, B., Lundeberg, J., Carlén, M., Göritz, C., & Frisén, J. (2018) · Cell · doi:10.1016/j.cell.2018.02.004 · Cited by 391 · cited 1×
“The glial scar tissue formed by subpopulations of perivascular cells, called type a pericytes, is extremely important for restoring tissue integrity and is a target for the development of therapies to promote axonal regeneration after CNS injury (Dias et al., 2018).”
BackgroundRong, Y., Liu, W., Wang, J., Fan, J., Luo, Y., Li, L., Kong, F., Chen, J., Tang, P., & Cai, W. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1571-8 · Cited by 333
Sun, G., Li, G., Li, D., Huang, W., Zhang, R., Zhang, H., Duan, Y., & Wang, B. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.04.006 · Cited by 314 · cited 2×
“Stem cells may have potential tumorigenic risk and ethical concerns (Sun et al., 2018).”
BackgroundExtracellular matrix hydrogel therapies: In vivo applications and development
Spang, M. T., & Christman, K. L. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.12.019 · Cited by 304 · cited 1×
“The ECMcurrently used in preclinical modelsmainly includes spinal cord, brain, muscle, bone, tendon, heart, liver, lung, and fat (Spang and Christman, 2018).”
MethodHuang, J.-H., Yin, X.-M., Xu, Y., Xu, C.-C., Lin, X., Ye, F.-B., Cao, Y., & Lin, F.-Y. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2017.5063 · Cited by 292 · cited 1×
“After treatment with MSCs-Exos, the expression levels of pro-apoptotic proteins (Bax) and pro-inflammatory cytokines (TNF-α and IL-β) were significantly reduced, while the expression levels of anti-apoptotic (Bcl2) and anti-inflammatory (IL-10) proteins were increased (Huang et al., 2017).”
BackgroundJiang, D., Gong, F., Ge, X., Lv, C., Huang, C., Feng, S., Zhou, Z., Rong, Y., Wang, J., Ji, C., et al. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00665-8 · Cited by 282 · cited 1×
“In addition, they have been found to inhibit the activation of M1 microglia and type A1 astrocytes and reduce neuroinflammation (Jiang et al., 2020; Khalatbary, 2021).”
BackgroundFan, L., Liu, C., Chen, X., Zou, Y., Zhou, Z., Lin, C., Tan, G., Zhou, L., Ning, C., & Wang, Q. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b05293 · Cited by 275 · cited 2×
“, 2020; Murali and Holmes, 2021); 2) the ischemic and hypoxic environment at the injury site inevitably causes deterioration of the injected exosomes (Fan et al., 2018).”
BackgroundLiu, W.-Z., Ma, Z.-J., Li, J.-R., & Kang, X.-W. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02153-8 · Cited by 252
Sancho-Albero, M., Navascués, N., Mendoza, G., Sebastián, V., Arruebo, M., Martín-Duque, P., & Santamaría, J. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0437-z · Cited by 246 · cited 1×
“Exosomes have emerged as a promising vehicle for miRNA delivery to the central nervous system (Pegtel et al., 2010; Sancho-Albero et al., 2019).”
BackgroundRohde, E., Pachler, K., & Gimona, M. (2019) · Cytotherapy · doi:10.1016/j.jcyt.2018.12.006 · Cited by 234 · cited 1×
“Studies have shown that hucMSCs-Exos reduce apoptosis at the site of spinal cord injury, downregulate inflammatory factors and promote angiogenesis, axonal growth, and antifibrotic activity by activating the Wnt/β-linked protein pathway, while inhibiting microglia and astrocyte activation, thus playing an important ro…”
BackgroundBerberine-loaded M2 macrophage-derived exosomes for spinal cord injury therapy
Gao, Z.-S., Zhang, C.-J., Xia, N., Tian, H., Li, D.-Y., Lin, J.-Q., Mei, X.-F., & Wu, C. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.018 · Cited by 224 · cited 2×
“The bioavailability of Exos-berberine was upregulated by 3.2-fold compared to berberine solution alone (Gao et al., 2021).”
BackgroundInfluentialLiu, C., Hu, F., Jiao, G., Guo, Y., Zhou, P., Zhang, Y., Zhang, Z., Yi, J., You, Y., Li, Z., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01273-4 · Cited by 222
Self-citationMesenchymal stem cell-derived exosomes from different sources selectively promote neuritic outgrowth
Lopez-Verrilli, M. A., Caviedes, A., Cabrera, A., Sandoval, S., Wyneken, U., & Khoury, M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.01.061 · Cited by 207 · cited 1×
“They can be obtained from tissues such as bone marrow, umbilical cord, dental pulp, menstrual blood, and fat, and can be isolated from autologous or allogeneic sources (Lopez-Verrilli et al., 2016; Sykova et al., 2021).”
BackgroundRegeneration of Spinal Cord Connectivity Through Stem Cell Transplantation and Biomaterial Scaffolds
Katoh, H., Yokota, K., & Fehlings, M. G. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00248 · Cited by 197 · cited 2×
“Furthermore, biodegradability, low immunogenicity, simple design (Katoh et al., 2019), and the ability to provide structural support for axonal regeneration are all equally important attributes (Liu et al.”
BackgroundWang, L., Pei, S., Han, L., Guo, B., Li, Y., Duan, R., Yao, Y., Xue, B., Chen, X., & Jia, Y. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000494652 · Cited by 187 · cited 1×
“BMSCs-Exos reduce the proportion of A1 astrocytes through the activation of transplanted NF-κB, which facilitates functional recovery after SCI (Wang et al., 2018).”
BackgroundLi, D., Zhang, P., Yao, X., Li, H., Shen, H., Li, X., Wu, J., & Lu, X. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00845 · Cited by 180 · cited 1×
“Injection of miRNA-133b-modified BMSCs-Exos through the tail vein of SCI rats was found to reduce the volume of the injury site, promote axonal regeneration, and activate ERK1/2, STAT3, and CREB, which are involved in neuronal survival and axonal regeneration (Li et al., 2018).”
BackgroundHuang, J.-H., Xu, Y., Yin, X.-M., & Lin, F.-Y. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2019.10.043 · Cited by 179
Xu, Y., Zhou, J., Liu, C., Zhang, S., Gao, F., Guo, W., Sun, X., Zhang, C., Li, H., Rao, Z., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120596 · Cited by 179 · cited 1×
“In vivo, the number of Nestin/ BLBP cells and Nestin/β-Tubulin III cells were higher in the DSCMgel, compared with the DNM-gel 14 days after implantation, indicating that the implantedDSCM-gel effectively promoted the differentiation of endogenous NSPC into neurons rather than glial cells (Xu et al., 2021).”
MethodSelf-citationLu, Y., Zhou, Y., Zhang, R., Wen, L., Wu, K., Li, Y., Yao, Y., Duan, R., & Jia, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00209 · Cited by 176 · cited 2×
“However, cell therapy for spinal cord injury may have the following disadvantages: most of the cells transplanted intravenously pooled at the lung and liver and could not fully exploit their effects at the site of SCI (Lu et al., 2019).”
BackgroundSelf-citationNakazaki, M., Morita, T., Lankford, K. L., Askenase, P. W., & Kocsis, J. D. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12137 · Cited by 176 · cited 1×
“BMSCExos reverse blood-spinal cord barrier leakage and reduce edema, which leads to improved pericyte coverage and better functional recovery after injury (Lu et al., 2019; Nakazaki et al., 2021; Zhou et al., 2022).”
BackgroundPericytes impair capillary blood flow and motor function after chronic spinal cord injury
Li, Y., Lucas-Osma, A. M., Black, S., Bandet, M. V., Stephens, M. J., Vavrek, R., Sanelli, L., Fenrich, K. K., Di Narzo, A. F., Dracheva, S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4331 · Cited by 164 · cited 1×
“After SCI, pericytes play an important role in the regulation of capillary tone and spinal cord blood flow (Li et al., 2017).”
BackgroundCaron, I., Rossi, F., Papa, S., Aloe, R., Sculco, M., Mauri, E., Sacchetti, A., Erba, E., Panini, N., Parazzi, V., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.024 · Cited by 161 · cited 2×
“This was ultimately shown to significantly immunomodulate the pro-inflammatory environment and increase the number of M2macrophages in a mouse SCI model (Caron et al., 2016).”
BackgroundZhong, D., Cao, Y., Li, C.-J., Li, M., Rong, Z.-J., Jiang, L., Guo, Z., Lu, H.-B., & Hu, J.-Z. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370219895491 · Cited by 158
Li, R., Zhao, K., Ruan, Q., Meng, C., & Yin, F. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-2146-x · Cited by 155
Liu, W., Tang, P., Wang, J., Wu, Y., Ge, X., Rong, Y., Ji, C., Wang, Z., Bai, J., Fan, J., et al. (2021) · Journal of Pineal Research · doi:10.1111/jpi.12769 · Cited by 152
Papa, S., Caron, I., Erba, E., Panini, N., Paola, M. D., Mariani, A., Colombo, C., Ferrari, R., Pozzer, D., Zanier, E. R., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.015 · Cited by 150 · cited 1×
“Studies have demonstrated that minocycline nanoparticles, when given acutely in a mouse SCI model, can effectively modulate resident microglia, reduce inflammatory responses, and maintain a conducive environment for regeneration (Papa et al., 2016).”
BackgroundWang, Y., Lai, X., Wu, D., Liu, B., Wang, N., & Rong, L. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02148-5 · Cited by 150 · cited 1×
“In this context, many new treatments for SCI are being developed (Yi and Wang, 2021).”
BackgroundAdvances in regenerative therapies for spinal cord injury: a biomaterials approach
Seifalian, A., Tsintou, M., & Dalamagkas, K. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.156966 · Cited by 144 · cited 2×
“In terms of morphology and diameter, the fibers have similarities to natural ECM and thus can provide a conducive environment for neural regeneration (Tsintou et al., 2015).”
BackgroundYuan, X., Wu, Q., Wang, P., Jing, Y., Yao, H., Tang, Y., Li, Z., Zhang, H., & Xiu, R. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00319 · Cited by 142 · cited 2×
“Pericytes surround the endothelial cells of capillaries and small veins that are located throughout the body and are important components of the neurovascular unit (Yuan et al., 2019).”
BackgroundZhang, L., Fan, C., Zhao, Y., Zhuang, Y., Liu, X., Zhao, Y., Chen, B., Xiao, Z., Chen, Y., & Dai, J. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001896 · Cited by 139
Hong, J. Y., Seo, Y., Davaa, G., Kim, H.-W., Kim, S. H., & Hyun, J. K. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.11.012 · Cited by 134 · cited 1×
“After spinal cord contusion in rats, application of decellularized extracellular matrix (dECM) hydrogel modulated M1 type macrophage polarization toward the M2 type, reduced the size of the injury gap, and promoted motor function recovery up to 8 weeks postinjury (Hong et al., 2020).”
MethodRole and prospects of regenerative biomaterials in the repair of spinal cord injury
Wang, B., Liu, S., & Xie, Y. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.253512 · Cited by 134 · cited 2×
“Biomaterial scaffolds should have properties such as appropriate porosity, permeability, and good cytocompatibility (Liu et al., 2019), and provide support for migration, adhesion, proliferation and”
BackgroundWang, C., Wang, M., Xia, K., Wang, J., Cheng, F., Shi, K., Ying, L., Yu, C., Xu, H., Xiao, S., et al. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.01.029 · Cited by 131 · cited 1×
“In this context, many new treatments for SCI are being developed (Yi and Wang, 2021).”
BackgroundAdvances in Biomaterial‐Based Spinal Cord Injury Repair
Shen, H., Fan, C., You, Z., Xiao, Z., Zhao, Y., & Dai, J. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202110628 · Cited by 131 · cited 3×
“differentiation of neuronal cells (Shen et al., 2021).”
BackgroundMethodInfluentialRecent advances in nanotherapeutic strategies for spinal cord injury repair
Song, Y. H., Agrawal, N. K., Griffin, J. M., & Schmidt, C. E. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.011 · Cited by 130 · cited 1×
“Among them, quantum dots and carbon nanotubes have great potential in spinal cord injury repair due to their small size, which can promote extravasation and systemic clearance of the blood-spinal cord barrier and maintain high neurobiological activity after cellular uptake (Song et al., 2019).”
BackgroundStrategies and prospects of effective neural circuits reconstruction after spinal cord injury
Yang, B., Zhang, F., Cheng, F., Ying, L., Wang, C., Shi, K., Wang, J., Xia, K., Gong, Z., Huang, X., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2620-z · Cited by 128 · cited 3×
“Further, reactive astrocytes and oligodendrocyte precursor cells were activated to secrete chondroitin sulfate proteoglycans (CSPGs), causing glial scar formation, which formed a physical barrier to inhibit axonal growth (Yang et al., 2020).”
BackgroundInfluentialExosomes secreted from miRNA-29b-modified mesenchymal stem cells repaired spinal cord injury in rats
Yu, T., Zhao, C., Hou, S., Zhou, W., Wang, B., & Chen, Y. (2019) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20198735 · Cited by 127 · cited 1×
“Similarly, BMSCs-Exos injected with miRNA-29b were shown to decreased the expression of GFAP and concomitantly, increase the expression of the NF200 and GAP-43 in neurons following SCI (Yu et al., 2019).”
BackgroundmiR-126 promotes angiogenesis and attenuates inflammation after contusion spinal cord injury in rats
Hu, J., Zeng, L., Huang, J., Wang, G., & Lu, H. (2015) · Brain Research · doi:10.1016/j.brainres.2015.02.036 · Cited by 126 · cited 1×
“A study found that elevated miR-126 levels inhibited the inflammatory response, promoted vascularization, and improved functional recovery after SCI (Hu et al., 2015).”
BackgroundSun, Y., Yang, C., Zhu, X., Wang, J., Liu, X., Yang, X., An, X., Liang, J., Dong, H., Jiang, W., et al. (2019) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36675 · Cited by 124 · cited 2×
“3D bioprinting technology has been applied to a variety of tissues including bone, cartilage, vascular systems, muscle and heart, but there are relatively few studies regarding SCI (Koffler et al., 2019; Sun et al., 2019; Hou et al., 2022).”
BackgroundSelf-citationJia, Y.-J., Zhou, Y., Wen, L.-L., Li, Y.-F., Wu, K.-M., Duan, R.-R., Yao, Y.-B., Jing, L.-J., Gong, Z., & Teng, J.-F. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.314323 · Cited by 124 · cited 1×
“BMSCExos reverse blood-spinal cord barrier leakage and reduce edema, which leads to improved pericyte coverage and better functional recovery after injury (Lu et al., 2019; Nakazaki et al., 2021; Zhou et al., 2022).”
BackgroundPapa, S., Vismara, I., Mariani, A., Barilani, M., Rimondo, S., Paola, M. D., Panini, N., Erba, E., Mauri, E., Rossi, F., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.03.034 · Cited by 122 · cited 1×
“Moreover, hucMSCs encapsulated in hydrogels secrete chemokines that are associated with neuronal protection by reducing N-methyl-D-aspartate (NMDA) receptor expression and extracellular glutamate levels to protect neurons from excitotoxicity and/or contribute to the survival of neuronal proteins in axons and promote l…”
BackgroundLi, C., Jiao, G., Wu, W., Wang, H., Ren, S., Zhang, L., Zhou, H., Liu, H., & Chen, Y. (2019) · Cell Transplantation · doi:10.1177/0963689719870999 · Cited by 120 · cited 1×
“In vitro experiments revealed that BMSCs-Exos decreased the expression levels of caspase-3, caspase-9 and Bax proteins and increased the expression level of Bcl2 in primary neurons (Li et al., 2019).”
BackgroundShao, M., Jin, M., Xu, S., Zheng, C., Zhu, W. P., Ma, X., & Lv, F. (2020) · Inflammation · doi:10.1007/s10753-020-01230-z · Cited by 120
Chen, C., Zhao, M., Zhang, R., Lu, G., Zhao, C., Fu, F., Sun, H., Zhang, S., Tu, Y., & Li, X. (2017) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36011 · Cited by 117 · cited 1×
“At the same time, the motor function and the outcome of electrophysiological experiment were significantly recovered in animal SCI models (Chen et al., 2017).”
BackgroundLiu, S., Schackel, T., Weidner, N., & Puttagunta, R. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00430 · Cited by 116 · cited 1×
“, 2019), and the ability to provide structural support for axonal regeneration are all equally important attributes (Liu et al., 2017).”
BackgroundExtracellular Vesicles as an Emerging Frontier in Spinal Cord Injury Pathobiology and Therapy
Dutta, D., Khan, N., Wu, J., & Jay, S. M. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.01.003 · Cited by 112 · cited 1×
“Exosomes can be detected in all body fluids, including urine, blood and cerebrospinal fluid (Dutta et al., 2021).”
BackgroundChang, Q., Hao, Y., Wang, Y., Zhou, Y., Zhuo, H., & Zhao, G. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.02.015 · Cited by 109 · cited 1×
“Studies have shown that human BMSCs-Exos are commonly available and can play a good neuroprotective role in the treatment of SCI (Chang et al., 2021).”
BackgroundMu, J., Li, L., Wu, J., Huang, T., Zhang, Y., Cao, J., Ma, T., Chen, J., Zhang, C., Zhang, X., et al. (2022) · Biomaterials Science · doi:10.1039/d1bm01722e · Cited by 107
Self-citationEmerging Exosomes and Exosomal MiRNAs in Spinal Cord Injury
Feng, J., Zhang, Y., Zhu, Z., Gu, C., Waqas, A., & Chen, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.703989 · Cited by 106 · cited 1×
“Currently, there are many different types of cell transplantation strategies used in therapeutic studies of SCI, including NSCs, MSCs, olfactory ensheathing cells, and SCs (Feng et al., 2021).”
BackgroundZhou, W., Silva, M., Feng, C., Zhao, S., Liu, L., Li, S., Zhong, J., & Zheng, W. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02248-2 · Cited by 101 · cited 1×
“It was shown that intravenous administration of hPMSCs-Exos effectively increased the expression of the neural stem/progenitor cell marker SOX2GFAPPAX6Nestincells in the spinal cord (Deng et al., 2021; Zhou et al., 2021).”
BackgroundBio-Scaffolds as Cell or Exosome Carriers for Nerve Injury Repair
Poongodi, R., Chen, Y.-L., Yang, T.-H., Huang, Y.-H., Yang, K. D., Lin, H., & Cheng, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413347 · Cited by 97
Romanelli, P., Bieler, L., Scharler, C., Pachler, K., Kreutzer, C., Zaunmair, P., Jakubecova, D., Mrowetz, H., Benedetti, B., Rivera, F. J., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01225 · Cited by 97 · cited 1×
“In recent years, exosomes have been recognized as paracrine factors released by almost all types of cells (Romanelli et al., 2019).”
BackgroundLuo, Z., Peng, W., Xu, Y., Xie, Y., Liu, Y., Lu, H., Cao, Y., & Hu, J. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.09.026 · Cited by 96 · cited 2×
“OTULIN protein in M2-Exos promotes angiogenesis after SCI by activating the Wnt/β-Catenin signaling pathway and triggering angiogenesis-related gene expression in spinal microvascular endothelial cells (Luo et al., 2021).”
BackgroundMesenchymal Stem Cell-Derived Exosomes: Hope for Spinal Cord Injury Repair
Ren, Z., Qi, Y., Sun, S., Tao, Y., & Shi, R. (2020) · Stem Cells and Development · doi:10.1089/scd.2020.0133 · Cited by 91 · cited 1×
“, 2019), reducing CSPGs, and maintaining the integrity of the blood-spinal cord barrier (Ren et al., 2020).”
BackgroundCheng, J., Chen, Z., Liu, C., Zhong, M., Wang, S., Sun, Y., Wen, H., & Shu, T. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0025 · Cited by 87
Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis
Syková, E., Cizkova, D., & Kubinová, Š. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.695900 · Cited by 87 · cited 1×
“They can be obtained from tissues such as bone marrow, umbilical cord, dental pulp, menstrual blood, and fat, and can be isolated from autologous or allogeneic sources (Lopez-Verrilli et al., 2016; Sykova et al., 2021).”
BackgroundKang, J., & Guo, Y. J. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03545-9 · Cited by 86 · cited 2×
“Furthermore, biodegradability, low immunogenicity, simple design (Katoh et al., 2019), and the ability to provide structural support for axonal regeneration are all equally important attributes (Liu et al., 2017).”
BackgroundGu, J., Jin, Z., Wang, C. M., Xue, Y., Mao, Y. Q., & Chen, S. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s237502 · Cited by 84
Pan, D., Li, Y., Yang, F., Lv, Z., Zhu, S., Shao, Y., Huang, Y., Ning, G., & Feng, S. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02215-x · Cited by 81 · cited 1×
“SCDEs can stimulate the expression of Toll-like receptors (TLR2) in astrocytes after SCI and reduce the deposition of CSPGs through NF-κB/PI3K signaling, thereby promoting functional recovery after SCI in mice (Pan et al., 2021).”
BackgroundZhao, C., Zhou, X., Qiu, J., Xin, D., Li, T., Chu, X., Yuan, H., Wang, H., Wang, Z., & Wang, D. (2019) · Drug Design, Development and Therapy · doi:10.2147/dddt.s209636 · Cited by 80
Peng, W., Wan, L., Luo, Z., Xie, Y., Liu, Y., Huang, T., Lü, H., & Hu, J. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/1695087 · Cited by 80 · cited 1×
“MG-Exos may act as an antioxidant through activation of the Keap1/Nrf2/HO1 pathway to promote functional recovery after SCI (Peng et al., 2021).”
BackgroundBiomaterial-based extracellular vesicle delivery for therapeutic applications
Murali, V. P., & Holmes, C. A. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.01.010 · Cited by 80 · cited 1×
“In the process of SCI repair, cell-derived exosomes are an extremely beneficial factor in the treatment of SCI, whereas, direct injection of cellderived exosomes into the SCI site has some limitations: 1) the most common way to delivery exosomes into the sites of injury is via local injection, nevertheless, thismay le…”
BackgroundZhang, C., Zhang, C., Xu, Y., Li, C., Cao, Y. B., & Li, P. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135399 · Cited by 76 · cited 1×
“In addition, another study showed that hPMSCs-Exos promoted the tubular formation of endothelial cells in vitro and new vessel formation in vivo, and altered the recovery of sensory-motor function in SCI mice (Zhang et al., 2020).”
ResultKim, G.-U., Sung, S., Kang, K., Choi, J.-H., Lee, S., Sung, M. K., Yang, S. Y., Kim, S., Kim, Y. I., Lim, J., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413672 · Cited by 75 · cited 1×
“MSCs possess a variety of growth factors and cytokines, and have anti-inflammatory effects, which are valuable in the treatment of SCI, but there are still some limitations when directly transplanting MSCs into target tissues (Kim et al., 2021; Liu W. Z. et al., 2021).”
BackgroundSheng, X., Zhao, J., Li, M., Xu, Y., Zhou, Y., Xu, J., He, R., Lü, H., Wu, T., Duan, C., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.772205 · Cited by 74
Zhang, B., Lin, F., Dong, J., Liu, J., Ding, Z., & Xu, J. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.54302 · Cited by 73
An Injectable, Calcium Responsive Composite Hydrogel for the Treatment of Acute Spinal Cord Injury
McKay, C. A., Pomrenke, R. D., McLane, J. S., Schaub, N. J., DeSimone, E. K., Ligon, L. A., & Gilbert, R. J. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am4027423 · Cited by 70 · cited 1×
“Most hydrogels exhibit tunable mechanical properties that simulate those of soft tissues in the central nervous system (McKay et al., 2014).”
BackgroundLocally Applied Stem Cell Exosome-Scaffold Attenuates Nerve Injury-Induced Pain in Rats
Hsu, J., Shiue, S., Yang, K. D., Shiue, H.-S., Hung, Y.-W., Pannuru, P., Poongodi, R., Lin, H.-Y., & Cheng, J. (2020) · Journal of Pain Research · doi:10.2147/jpr.s286771 · Cited by 70
Fan, L., Dong, J., He, X., Zhang, C., & Zhang, T. (2021) · Human & Experimental Toxicology · doi:10.1177/09603271211003311 · Cited by 70
Targeted Delivery of Mesenchymal Stem Cell-Derived Nanovesicles for Spinal Cord Injury Treatment
Lee, J., Kyung, J. W., Kumar, H., Kwon, S. P., Song, S. Y., Han, I.-B., & Kim, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114185 · Cited by 68 · cited 1×
“Recent studies suggest that the role of MSCs in the treatment of SCI is attributed to their paracrine mechanism and that exosomes may play an important role in this process (Lee et al., 2020; Liu et al., 2020).”
BackgroundWang, X., Qiang, S., Jianing, D., Jiaming, L., Lin, F., Cai, B., Yuanyuan, C., Guowang, Z., Xu, J., & Xiaofeng, L. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02565-w · Cited by 68 · cited 1×
“Disruption of the blood-spinal cord barrier leads to neurological deficits by infiltration of inflammatory substances, production of neurotoxic substances, and disruption of neuronal and synaptic function (Xin et al., 2021).”
BackgroundSiRNA in MSC-derived exosomes silences CTGF gene for locomotor recovery in spinal cord injury rats
Huang, W., Qu, M., Li, L., Liu, T., Lin, M., & Yu, X. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02401-x · Cited by 67
A multi-channel collagen scaffold loaded with neural stem cells for the repair of spinal cord injury
Wang, B., Liu, S., Xie, Y., Wang, L., Tai, C., Chen, D., Mu, D., & Cui, Y. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.310698 · Cited by 66
Tang, F., Tang, J., Zhao, Y., Zhang, J., Xiao, Z., Chen, B., Han, G., Yin, N., Jiang, X., Zhao, C., et al. (2021) · Science China Life Sciences · doi:10.1007/s11427-021-1985-5 · Cited by 65
Poulen, G., Aloy, E., Bringuier, C. M., Mestre‐Francés, N., Artus, E. V. F., Cardoso, M., Perez, J., Goze‐Bac, C., Boukhaddaoui, H., Lonjon, N., et al. (2021) · Theranostics · doi:10.7150/thno.61833 · Cited by 65 · cited 2×
“Microglia and macrophages are considered to be important players in the pathophysiology of spinal cord injury (Poulen et al., 2021).”
BackgroundSpinal Cord Repair: From Cells and Tissue Engineering to Extracellular Vesicles
Guo, S., Redenski, I., & Levenberg, S. (2021) · Cells · doi:10.3390/cells10081872 · Cited by 64 · cited 2×
“…method; however, as exosomes are precipitates obtained by multiple centrifugations and filtrations, isolation of non-vesicular entities from exosomes has not been fully achieved, and there is no method that can achieve both high recovery and specificity of the isolated exosomes (Guo et al., 2021).”
MethodZhang, C., Li, D., Hu, H., Wang, Z., An, J., Gao, Z., Zhang, K., Mei, X., Wu, C., & Tian, H. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01123-9 · Cited by 64
Li, C., Qin, T., Liu, Y., Wen, H., Zhao, J., Luo, Z., Peng, W., Lü, H., Duan, C., Cao, Y. B., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.783017 · Cited by 63
Pan, D., Zhu, S., Zhang, W., Wei, Z., Yang, F., Guo, Z., Ning, G., & Feng, S. (2021) · Biotechnology Letters · doi:10.1007/s10529-021-03198-8 · Cited by 56 · cited 1×
“Moreover, SCDEs increased autophagy after SCI and reduce PTEN activity by activating vincristine receptor B signaling, thereby reducing apoptosis and promoting recovery of motor function (Pan et al., 2022).”
BackgroundHuang, W., Lin, M., Yang, C., Wang, F.-M., Zhang, M., Gao, J., & Yu, X. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/1634917 · Cited by 55
3D spheroids of human placenta-derived mesenchymal stem cells attenuate spinal cord injury in mice
Deng, J., Li, M., Meng, F., Liu, Z., Wang, S., Zhang, Y., Li, M., Li, Z., Zhang, L., & Tang, P. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04398-w · Cited by 52 · cited 1×
“It was shown that intravenous administration of hPMSCs-Exos effectively increased the expression of the neural stem/progenitor cell marker SOX2GFAPPAX6Nestincells in the spinal cord (Deng et al., 2021; Zhou et al., 2021).”
BackgroundWertheim, L., Edri, R., Goldshmit, Y., Kagan, T., Noor, N., Ruban, A., Shapira, A., Gat‐Viks, I., Assaf, Y., & Dvir, T. (2022) · Advanced Science · doi:10.1002/advs.202105694 · Cited by 50 · cited 1×
“SCI is followed by a series of secondary pathophysiological changes that induce an inflammatory response and neuronal apoptosis at the site of the injury, followed by cavity formation and astrocytic scars, leading to the inhibition of axonal regeneration (Wertheim et al., 2022).”
BackgroundHuman Epidural AD–MSC Exosomes Improve Function Recovery after Spinal Cord Injury in Rats
Sung, S., Seo, M., Kim, Y., Kang, K., Choi, J.-H., Lee, S., Sung, M. K., Yim, S., Lim, J., Seok, H.-G., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10030678 · Cited by 48 · cited 1×
“In addition to the MSC-Exos mentioned above, studies have shown that human epidural adipose tissue mesenchymal stem cellderived exosomes (ADSC-Exos) can modulate the inflammatory response (Sung et al., 2022).”
BackgroundPericytes Make Spinal Cord Breathless after Injury
de Almeida, V. M., Paiva, A. E., Sena, I. F. G., Mintz, A., Magno, L. A. V., & Birbrair, A. (2017) · The Neuroscientist · doi:10.1177/1073858417731522 · Cited by 47 · cited 1×
“Also, the degree of pericyte-dependent vasoconstriction in patients with spinal cord injury varies depending on the degree of injury (Almeida et al., 2018).”
BackgroundChen, J., Zhang, C., Li, S., Li, Z., Lai, X., & Xia, Q. (2021) · Journal of Immunology Research · doi:10.1155/2021/8100298 · Cited by 46 · cited 1×
“Meanwhile, in vitro studies revealed that FTY720-NSCs-Exos had a protective effect on the SCMEC barrier in a hypoxic environment (Chen et al., 2021).”
BackgroundHe, X., Zhang, J., Guo, Y., Yang, X., Huang, Y., & Hao, D. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2022.03.007 · Cited by 45
Rapid and effective treatment of traumatic spinal cord injury using stem cell derived exosomes
Mu, J., Wu, J., Cao, J. X., Ma, T., Li, L., Feng, S., & Gao, J. (2021) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2021.10.002 · Cited by 44
Efficacy of riluzole in the treatment of spinal cord injury: a systematic review of the literature
Srinivas, S., Wali, A. R., & Pham, M. H. (2019) · Neurosurgical FOCUS · doi:10.3171/2019.1.focus18596 · Cited by 43 · cited 1×
“For instance, adverse effects have been shown in several studies, including pancreatitis, lung disease, and neutropenia (Srinivas et al., 2019).”
BackgroundHan, C., Liu, F., Zhang, Y., Chen, W., Luo, W. D., Ding, F., Lu, L., Wu, C., & Li, Y. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.713021 · Cited by 43
Zhou, M., Hu, M., He, S., Li, B., Liu, C., Min, J., & Hong, L. (2018) · Medical Science Monitor · doi:10.12659/msm.909509 · Cited by 41 · cited 1×
“SCDEs promoted the regeneration of axonal growth, and sequencing results indicated that SCDEs released from the areas of axonal injury contained miRNAs associated with regeneration (Zhou et al., 2018).”
ResultGhafouri‐Fard, S., Niazi, V., Hussen, B. M., Omrani, M. D., Taheri, M. N., & Basiri, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.653296 · Cited by 41 · cited 1×
“Finally, the immune system does not perceive exosomes as foreign bodies, making them more suitable for clinical application than stem cells (Ghafouri-Fard et al., 2021).”
BackgroundHe, W., Zhang, X., Li, X., Ju, D., Mao, T., Lu, Y., Gu, Y., Qi, L., Wang, Q., Wu, Q., et al. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00792d · Cited by 40
Self-citationPericytes Act as Key Players in Spinal Cord Injury
Picoli, C. C., Coimbra-Campos, L. M. C., Guerra, D. A. P., Silva, W. N., Prazeres, P. H. D. M., Costa, A. C., Magno, L. A. V., Romano-Silva, M. A., Mintz, A., & Birbrair, A. (2019) · The American Journal of Pathology · doi:10.1016/j.ajpath.2019.03.008 · Cited by 39 · cited 1×
“Pericytes are equally important for vascular development, maturation, permeability, and maintenance of the integrity of the blood-spinal cord barrier (Picoli et al., 2019).”
BackgroundCombined bioscaffold with stem cells and exosomes can improve traumatic brain injury
Yuan, J., Botchway, B. O. A., Zhang, Y., Wang, X., & Liu, X. (2019) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09927-x · Cited by 38
Wei, G., An, G., Shi, Z.-W., Wang, K., Guan, Y., Wang, Y., Han, B. R., Yu, E.-M., Li, P., Dong, D.-M., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000468057 · Cited by 38 · cited 2×
“Numerous studies show that miRNAs can regulate cell proliferation, differentiation, apoptosis, and are closely associated with pathological processes after SCI (e.g., inflammatory reaction, demyelination, oxidative stress, and neuronal apoptosis) (Wei et al., 2017).”
BackgroundLiu, B., Zheng, W., Li, D., Fu, S., & Shi, E. (2021) · Tissue and Cell · doi:10.1016/j.tice.2021.101678 · Cited by 37
Combinational Treatment of Bioscaffolds and Extracellular Vesicles in Spinal Cord Injury
Wang, X., Botchway, B. O. A., Zhang, Y., Yuan, J., & Liu, X. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00081 · Cited by 33
Jia, Y., Lu, T., Chen, Q., Pu, X., Ji, L., Yang, J., & Luo, C. (2021) · Acta Neurochirurgica · doi:10.1007/s00701-021-04829-9 · Cited by 32
Jia, Y., Yang, J., Lu, T., Pu, X., Chen, Q., Ji, L., & Luo, C. (2021) · Regenerative Therapy · doi:10.1016/j.reth.2021.08.007 · Cited by 32
Li, C., Qin, T., Zhao, J., He, R., Wen, H., Duan, C., Lü, H., Cao, Y. B., & Hu, J. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.725573 · Cited by 32
Lazar, S. V., Mor, S., Chen, J., Hao, D., & Wan, A. (2021) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2021.10 · Cited by 31 · cited 1×
“Exosomes combined with biomaterial scaffolds have shown good therapeutic effects in research related to tissue regeneration and angiogenesis (Table 2) (Lazar et al., 2021).”
BackgroundZhang, C., Deng, R., Zhang, G., He, X., Chen, H., Chen, B., Wan, L., & Kang, X. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.847444 · Cited by 28 · cited 2×
“Extracellular vesicles can be divided into exosomes, apoptotic body, and vesicles based on the release mechanism and size, with exosomes having the smallest diameter (Zhang et al., 2022).”
BackgroundStem cell-derived exosomes as a cell free therapy against spinal cord injury
Khalatbary, A. R. (2021) · Tissue and Cell · doi:10.1016/j.tice.2021.101559 · Cited by 27 · cited 3×
“In addition, they have been found to inhibit the activation of M1 microglia and type A1 astrocytes and reduce neuroinflammation (Jiang et al., 2020; Khalatbary, 2021).”
BackgroundNeuroactive Peptide Nanofibers for Regeneration of Spinal Cord after Injury
Sever, M., Yılmaz, C., Demirel, A., Kılınç, M. C., Doğan, İ., Caglar, Y. S., Guler, M. O., & Tekinay, A. B. (2020) · Macromolecular Bioscience · doi:10.1002/mabi.202000234 · Cited by 24 · cited 1×
“Recently, self-assembled PAs showed promising results in regard to neural differentiation in vitro and neural regeneration in vivo, demonstrating the potential of these materials for effective treatment of CNS injuries (Sever-Bahcekapili et al., 2021).”
BackgroundA meta-analysis of exosome in the treatment of spinal cord injury
Yi, H., & Wang, Y. (2021) · Open Medicine · doi:10.1515/med-2021-0304 · Cited by 23 · cited 1×
“In this context, many new treatments for SCI are being developed (Yi and Wang, 2021).”
BackgroundHou, Y., Liu, X., Guo, Y., Liu, D., Guo, P., & Liu, J. (2022) · World Neurosurgery · doi:10.1016/j.wneu.2022.02.012 · Cited by 23 · cited 2×
“3D bioprinting technology has been applied to a variety of tissues including bone, cartilage, vascular systems, muscle and heart, but there are relatively few studies regarding SCI (Koffler et al., 2019; Sun et al., 2019; Hou et al., 2022).”
Background
Cited by
Role of Stem Cell-Derived Exosomes and microRNAs in Spinal Cord Injury
Hwang, J., Jang, S., Kim, C., Lee, S., & Jeong, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813849 · Cited by 37
“They also have a neuroprotective, angiogenic, and immunomodulatory effect and easily cross the blood–spinal-cord barrier to promote axonal regeneration [19,76].”
BackgroundDecellularized extracellular matrix in the treatment of spinal cord injury
Jiang, W., Zhang, X., Yu, S., Yan, F., Chen, J., Liu, J., & Dong, C. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114506 · Cited by 31
Self-citationLi, L., Wang, Y., Xu, Y., Xu, J., Zhao, Y., Cheng, Z., Fang, Y., Miao, Y., & Zhang, X. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.05.048 · Cited by 29
Self-citationWang, G., Li, Q., Liu, S., Mo, L., Liu, B., Zhao, T., Liu, B., & Chen, Z. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101250 · Cited by 42
“…hyaluronic acid, gelatin, alginate, and extracellular matrix (ECM) are widely recognized for their three-dimensional structure, injectability, biode-gradability, and excellent compatibility with cells, making them extensively used in drug and cell delivery for regenerative medicine [14 – 16].”
BackgroundExtracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions
Choi, H. K., Chen, M., Goldston, L. L., & Lee, K.-B. (2024) · Nano Convergence · doi:10.1186/s40580-024-00426-5 · Cited by 26
Metadata
- Authors
- Zhang, X., Jiang, W., Lu, Y., Mao, T., Gu, Y., Ju, D., & Dong, C.
- Affiliations
- Nantong University (CN)
- Corresponding author
- Dong, Chuanming
- Venue
- Frontiers in Bioengineering and Biotechnology
- Publisher
- Frontiers Media SA
- Published
- 2023-03-13
- Volume
- 11
- Pages
- 1077825-1077825
- ISSN
- 2296-4185 (ISSN-L)
- PMC
- PMC10040754
- OpenAlex
- W4324088316
- Cited by
- 32
- References
- 121
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 9 · 2023: 6
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Bioengineering and Biotechnology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (82171380)
- Government of Jiangsu Province
- Topics
- Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- spinal cord injury, exosomes, stem cell-derived exosomes, biomaterial scaffolds, exosome delivery, neural repair, anti-inflammatory activity, cell therapy, regenerative medicine, blood-spinal cord barrier
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.